Literature DB >> 10895413

Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes.

V Weissig1, C Lizano, V P Torchilin.   

Abstract

The number of diseases found to be associated with defects of the mitochondrial genome has grown significantly over the past decade (Wallace 1999). Despite major advances in understanding mtDNA defects at the genetic and biochemical level, there is no satisfactory treatment available for the vast majority of patients and the exploration of gene therapeutic approaches is highly warranted. However, mitochondrial gene therapy still appears only theoretical and speculative. Any possibility for gene replacement depends on the use of a yet unavailable mitochondria-specific transfection vector. Mitochondria-specific vectors must posses two properties: they have to transport DNA to the side of mitochondria; they must not release DNA during endocytosis. Amphiphile compounds with delocalized cationic charge centers such as rhodamine 123 and the bolaamphiphile dequalinium have long been known to accumulate in mitochondria. Sufficient lipophilicity combined with delocalization of the positive charge to reduce the free energy change when moving from an aqueous to a hydrophobic environment are believed to be prerequisite for mitochondrial accumulation in response to the mitochondrial membrane potential. We have recently succeeded in preparing cationic vesicles made of dequalinium that we termed DQAsomes (Weissig et al. 1998a). We have shown that DQAsomes bind and protect DNA against DNase activity (Lasch et al. 1999). Based on the intrinsic property of dequalinium to preferentially accumulate in mitochondria in response to the electrochemical gradient at the mitochondrial membrane, we believe that DQAsomes can serve as a vector to deliver DNA to mitochondria in living cells. As a first step in the development of mitochondria-specific DNA delivery systems, we report here that DQAsome/DNA complexes selectively release DNA at cardiolipin-rich liposomes mimicking both the inner and the outer mitochondrial membrane. We demonstrate that DNA remains tightly associated with DQAsomes in the presence of an excess of anionic lipids other than cardiolipin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10895413     DOI: 10.1080/107175400266722

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  11 in total

Review 1.  From serendipity to mitochondria-targeted nanocarriers.

Authors:  Volkmar Weissig
Journal:  Pharm Res       Date:  2011-08-11       Impact factor: 4.200

2.  The utility of an isolated mitochondrial fraction in the preparation of liposomes for the specific delivery of bioactives to mitochondria in live mammalian cells.

Authors:  Mayura A Wagle; Laura E Martinville; Gerard G M D'Souza
Journal:  Pharm Res       Date:  2011-07-15       Impact factor: 4.200

Review 3.  Modifying the Mitochondrial Genome.

Authors:  Alexander N Patananan; Ting-Hsiang Wu; Pei-Yu Chiou; Michael A Teitell
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

Review 4.  Advances in therapeutic bacterial antisense biotechnology.

Authors:  John P Hegarty; David B Stewart
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-05       Impact factor: 4.813

Review 5.  Nanopreparations for organelle-specific delivery in cancer.

Authors:  Swati Biswas; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2013-11-21       Impact factor: 15.470

6.  Data ontology and an information system realization for web-based management of image measurements.

Authors:  Dimiter Prodanov
Journal:  Front Neuroinform       Date:  2011-11-25       Impact factor: 4.081

7.  Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile.

Authors:  John P Hegarty; Jacek Krzeminski; Arun K Sharma; Diana Guzman-Villanueva; Volkmar Weissig; David B Stewart
Journal:  Int J Nanomedicine       Date:  2016-08-01

Review 8.  Engineering Genetic Systems for Treating Mitochondrial Diseases.

Authors:  Yoon-Ha Jang; Sae Ryun Ahn; Ji-Yeon Shim; Kwang-Il Lim
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

Review 9.  Mitochondria-targeting particles.

Authors:  Amaraporn Wongrakpanich; Sean M Geary; Mei-ling A Joiner; Mark E Anderson; Aliasger K Salem
Journal:  Nanomedicine (Lond)       Date:  2014-11       Impact factor: 6.096

Review 10.  Recent Advances in Mitochondria-Targeted Gene Delivery.

Authors:  Yoon-Ha Jang; Kwang-Il Lim
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.